Glucagonoma screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Glucagonoma}} | {{Glucagonoma}} | ||
{{CMG}}{{AE}}{{PSD}} | |||
==Overview== | |||
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for insulinoma.<ref>USPTF.http://http://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=glucagonoma</ref> | |||
==Screening== | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
| Line 10: | Line 11: | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Revision as of 18:24, 8 October 2015
|
Glucagonoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Glucagonoma screening On the Web |
|
American Roentgen Ray Society Images of Glucagonoma screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]
Overview
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for insulinoma.[1]
Screening
References